logoThe People's Perspective on Medicine

Will Diabetes Drug Offer Promise for “Leaky Gut”?

Creating tiny organoids from stem cells allowed scientists to identify a crucial pathway in intestinal permeability and test metformin to treat it.
Celiac disease Small intestine lining damage. good and damaged villi . leaky gut progression

Researchers at the University of California, San Diego, have created a petri dish model for intestinal permeability. This condition, also known as “leaky gut,” leads to conditions associated with chronic inflammation such as atherosclerosis, dementia or inflammatory bowel disease. Although serious complications are best documented as a result of celiac disease, other researchers have found links between non-celiac permeability, microbiota imbalances and mood disorders such as anxiety or depression (Minerva Gastroenterologica e Dietologica, March 2017). Intestinal permeability has been difficult to treat, but now there is a treatment with promise for leaky gut.

A Model with Promise for Leaky Gut:

The UCSD scientists took stem cells from the intestines of patients with leaky gut syndrome. They grew these stem cells under special conditions that allowed them to form into miniature organs (Life Science Alliance, Feb. 10, 2020). These tiny balls of intestinal cells demonstrated that under certain types of stress, the tight junctions between intestinal cells start to disintegrate. Aging and tumor growth created such stress. So did certain types of bacteria. A stress-polarity signaling (SPS) pathway appears to be critical to this process.

The authors summarized:

“Using the combined synergy of patient-derived tissues and mouse and human organoid-based models, we showed that the SPS-pathway serves as a protective host response that is compromised in the aged gut and early during the initiation of colon cancers.”

The investigators identified a compound, occludin, that was a consistent marker for junction failure. Low occludin was linked to poor barrier function. They also found that the diabetes drug metformin can help reverse the permeability. Metformin-treated mini-guts produced six times more occludin than the untreated, stressed organoids. Since the mini-guts were created from different individuals’ stem cells, they offer the opportunity to test personalized medicines.

The Promise of Metformin:

For now, though, metformin looks very promising. The drug is already approved and has been prescribed for decades, to treat diabetes and for off-label uses such as prostate cancer, pulmonary fibrosis and thyroid nodules. Next, the team will want to test this medication in humans with leaky gut to see whether it helps relieve symptoms. 

The researchers conclude:

“These findings reveal the importance of the SPS-pathway in the gut and highlights its therapeutic potential for treating gut barrier dysfunction in aging, cancer, and dysbiosis.”

Rate this article
star-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-empty
4.5- 43 ratings
About the Author
Terry Graedon, PhD, is a medical anthropologist and co-host of The People’s Pharmacy radio show, co-author of The People’s Pharmacy syndicated newspaper columns and numerous books, and co-founder of The People’s Pharmacy website. Terry taught in the Duke University School of Nursing and was an adjunct assistant professor in the Department of Anthropology. She is a Fellow of the Society of Applied Anthropology. Terry is one of the country's leading authorities on the science behind folk remedies. .
Tired of the ads on our website?

Now you can browse our website completely ad-free for just $5 / month. Stay up to date on breaking health news and support our work without the distraction of advertisements.

Browse our website ad-free
Citations
  • Casella G et L, "Mood disorders and non-celiac gluten sensitivity." Minerva Gastroenterologica e Dietologica, March 2017. DOI: 10.23736/S1121-421X.16.02325-4
  • Ghosh P et al, "The stress polarity signaling (SPS) pathway serves as a marker and a target in the leaky gut barrier: Implications in aging and cancer." Life Science Alliance, Feb. 10, 2020. DOI: 10.26508/lsa.201900481
Join over 150,000 Subscribers at The People's Pharmacy

We're empowering you to make wise decisions about your own health, by providing you with essential health information about both medical and alternative treatment options.

No comments yet. Start the conversation!
Comments
Add your comment
* Be nice, and don't over share. View comment policy^